At 6:40 p.m. on a Friday, the ICU calls. They need a BiPAP machine interface for a patient with respiratory failure, an ostomy bag that will actually stay on friable skin, and dialysis-friendly dressings for a central line. Purchasing says the items are 'in stock.' The floor nurse says, 'Not the right ones.' That gap—between in stock and right—is where most emergency supply problems start.
I coordinate emergency medical supply logistics at a regional health system. I've handled 300+ rush orders in 9 years, including same-day turnarounds for OR and ICU teams. In my role triaging rush orders, I've learned that the visible problem is almost never the real one. The real problem usually started weeks earlier, in a spreadsheet.
The surface problem: the rush order
Everyone focuses on the rush order. Can we get it by 10 p.m.? Can we drive it across town? Can we borrow from another facility? Those are valid questions. But they're tactical. If you're constantly firefighting, you're probably treating symptoms.
When I'm triaging a rush order, I look at three things: time, feasibility, and risk. The risk part is where people get uncomfortable. A fast substitution can be worse than a late delivery. I knew I should verify a BiPAP mask interface before approving a substitute, but thought, 'A mask is a mask.' That was the one time it mattered. The patient developed a bridge-of-nose pressure injury. Not because the mask was defective—because it wasn't the right interface for that patient's anatomy and ventilation needs.
That's a red flag for any supply chain: when speed becomes the only metric.
The deeper cause: we buy SKUs, but patients don't use SKUs
Here's the thing most purchasing dashboards miss. A patient with kidney failure may be on hemodialysis, have an ostomy bag, need BiPAP at night, and have fragile skin from repeated tape and adhesive removal. If you don't understand how hemodialysis works—blood is filtered outside the body through a dialyzer, usually via a vascular access—you might not realize that the access site needs specific care. If you don't understand ostomy adhesive wear time, you might order a wafer that fails in 24 hours. If you don't understand BiPAP mask pressure points, you might focus on the machine rather than the interface.
These are not separate categories to the patient. They're one skin-integrity and infection-prevention problem. But in many hospitals, they sit in different budget silos: wound care, respiratory, ostomy, renal. That's the underlying bug.
I'm not 100% sure why some hospitals still treat all foam dressings as interchangeable. My best guess is that purchasing systems classify them by size and price, not adhesive chemistry. That works until you put a traditional acrylic adhesive on a patient with fragile skin—then you get skin tears, pain, and nurse time spent on re-dressing.
Where Mölnlycke fits—and where it doesn't
Mölnlycke Health Care Company (commonly searched as molnlycke) is a global medical device company with a portfolio that includes wound care, surgical, and infection prevention products. One of its better-known wound care lines is molnlycke mepilex with safetac technology. Safetac is a proprietary silicone adhesive. The idea is simple: it seals to intact skin but doesn't stick to the wound bed. In practice, that can mean less pain at dressing changes and less trauma to surrounding skin.
For patients with fragile skin—especially those on hemodialysis, with an ostomy bag, or using a BiPAP machine—that adhesive difference can be a game-changer. But it's not a no-brainer for every wound. If you're dealing with a heavily infected wound, significant necrotic tissue, or a wound that needs frequent debridement, Mepilex with Safetac may not be the right primary choice. That's not a knock on the product. It's just honest triage. The best dressing is the one that matches the wound, the exudate level, and the care plan.
This was accurate as of January 2025. Product availability and contract terms change fast, so verify current specifications and pricing with your Mölnlycke representative or group purchasing organization.
The cost of getting it wrong
The cost isn't just the rush freight. It's the downstream mess. When a BiPAP interface causes a pressure injury, you add wound care costs, nursing time, and possibly a longer stay. When an ostomy bag leaks, you change the appliance, the bedding, and sometimes the patient's morale. When a dialysis access dressing doesn't hold, you risk infection and missed treatment time.
I still kick myself for not pushing for a clinician-led SKU review earlier. We spent months substituting 'equivalent' products to save a few dollars per unit. Then we paid for it in nurse overtime and patient harm. One of my biggest regrets is treating supply chain as a back-office function instead of a clinical support function.
So glad we eventually standardized Safetac-based dressings for fragile skin. We almost went with a cheaper adhesive foam to hit a budget target. That would have meant more skin tears and more dressing changes. The savings would have evaporated by the second month.
Bottom line: the lowest unit price is often not the lowest total cost. In medical supplies, the total cost includes clinical time, patient outcomes, and the risk of rework.
The fix: three changes, none of them glamorous
I've tested enough rush-order workarounds to know that the solution isn't a better emergency vendor. It's preventing the emergency. Here's what actually works:
- Build a clinician-led SKU review across silos. Get wound care, respiratory, ostomy, and renal nurses in the same room. Map the patient pathways where these products intersect. If a patient can have all four needs at once, your inventory should reflect that.
- Standardize skin-safe basics, then allow exceptions. For fragile skin, products like Mölnlycke Mepilex with Safetac technology can be a sensible default. But keep alternatives for infected wounds, high exudate, or specific anatomies. The policy should say when not to use it.
- Treat BiPAP machine, ostomy bag, and hemodialysis supplies as skin-integrity products, not just equipment. That means correct sizing, adhesive knowledge, and regular skin assessment. It also means training. A nurse who understands how hemodialysis works is less likely to tape over a fistula site incorrectly.
None of this is as exciting as a same-day courier. But it's what stops the 6:40 p.m. calls.
What I'd tell a new supply chain manager
Don't confuse urgency with importance. The rush order is urgent. The SKU decision is important. If you only respond to urgency, you'll never fix the important stuff. In my experience, the best emergency plan is a boring standard work plan.
And when you evaluate products, ask the uncomfortable question: 'Who is this not for?' If a vendor can't answer that, be skeptical. If a clinician can answer it, listen. That's how you build trust—and better patient care.
Mölnlycke is one part of that picture. It's not the whole picture. But for wound care and surgical teams that deal with fragile skin, it's a name worth knowing. Just don't let the logo make the decision. Let the patient's skin, the wound, and the workflow make it.
